Full-Time

Business Development Representative

Confirmed live in the last 24 hours

HeartFlow

HeartFlow

501-1,000 employees

Non-invasive cardiac testing for heart disease

Healthcare

Compensation Overview

$125kAnnually

+ Total target compensation of $200,000 + Stock options

Senior

Philadelphia, PA, USA

Expect approximately 20-25% travel from a home office.

Category
Business Development
Business & Strategy
Required Skills
Sales
Requirements
  • Proven sales skills and track-record of sales achievement
  • Account development - Experience building and supporting strong clinical programs is preferred.
  • Clinical / technical proficiency - Quick learner able to grasp new clinical/technical information and then disseminate to customers.
  • Develop relationships with key account stakeholders, to include admin, admin support, key cardiologists, key referring physician practices, hospital marketing and key strategic personnel to drive awareness of a cCTA/FFRct pathway, broaden HeartFlow referrals, and deepen HeartFlow adoption.
  • Work in a cross functional capacity to coordinate field and HQ resources needed to support focused customers and execute program development plans, support sales, marketing, education and training.
  • Customer-focused mentality.
  • Ability to explain medical technologies to referring physicians and health care professionals.
  • Self-motivated and ability to initiate, organize, and complete projects.
  • Excellent problem-solving ability, especially under pressure.
  • Extremely strong work ethic.
  • Works well in a cross-functional team environment.
  • Ability to work effectively with customers from a wide range of technical and clinical backgrounds.
  • Excellent verbal and written communication skills. Professional etiquette.
  • Experience with Salesforce.com or similar CRM.
Responsibilities
  • Will work with key strategic HeartFlow accounts to drive growth and adoption of a cCTA and FFRct clinical pathway. In these accounts, the BDR will develop and execute business development plans working closely with the account’s key stakeholders
  • Facilitate cross-functional collaboration throughout the organization. Tools for program development could include key deployment of HeartFlow internal leadership and physician mentors, organizing and staffing of dinner programs, VIP Visits, organizing HeartFlow CT Pathway road-shows, referring physician office meetings, etc. This role will work closely with the other HeartFlow team members to include respective DSM, Marketing, Market Access, CT Apps, Product Development and Clinical
  • Increase HeartFlow usage within the designated key strategic HeartFlow account by: 1) Maintaining and building relationships with referring physicians and other key clinical stakeholders 2) Educating customers on HeartFlow’s value proposition by giving presentations / having discussions with referring MDs 3) Promoting / championing HeartFlow and building advocacy
  • Production/Success/Achievement of the Business Development Representative will be evaluated and based on performance in active/targeted accounts(metrics): 1) Meet / exceed quota for the strategic HeartFlow account (within existing customer locations) 2) cCTA growth (conversion of non-invasive tests) and FFRct penetration / case growth over baseline (% and $) in assigned accounts.
Desired Qualifications
  • Experience building and supporting strong clinical programs is preferred.
  • Knowledge of cardiac patient pathways and diagnostic technology is preferred.
  • Degree in Science, Medical, Business, Marketing or Technical field is preferred.
  • Prior experience in medical device, cardiology pharmaceuticals, cardiology radio-pharmaceuticals, hospital, or medical software is highly desired
  • Experience with introducing new cardiovascular technologies into hospitals is highly desired

HeartFlow provides a non-invasive cardiac test that helps visualize a patient's coronary arteries in detail. This technology allows physicians to diagnose and treat heart disease more effectively without the need for invasive procedures, which reduces risks for patients and costs for healthcare providers. HeartFlow's main products include the HeartFlow Analysis, which encompasses various analyses like FFRCT, RoadMap, Plaque, and HeartFlow Planner. These products have received FDA clearance and are available in the United States, the United Kingdom, Japan, and Canada. Unlike many competitors, HeartFlow focuses on providing a safer and more efficient diagnostic method for cardiovascular care. The company's goal is to enhance the quality of heart disease treatment through its advanced technology.

Company Stage

Series F

Total Funding

$858.5M

Headquarters

Redwood City, California

Founded

2010

Growth & Insights
Headcount

6 month growth

0%

1 year growth

0%

2 year growth

0%
Simplify Jobs

Simplify's Take

What believers are saying

  • HeartFlow closed a $215 million Series F funding round in April 2023.
  • The global non-invasive cardiac imaging market is projected to grow significantly.
  • HeartFlow's technology aligns with the trend towards value-based care in healthcare.

What critics are saying

  • Emerging AI-driven competitors could threaten HeartFlow's market share.
  • Algorithmic bias in AI models could lead to inaccurate diagnoses.
  • Integration into healthcare systems may face resistance due to complexity and cost.

What makes HeartFlow unique

  • HeartFlow offers the only combined anatomy, physiology, and plaque analysis for heart disease.
  • HeartFlow's non-invasive FFRCT Analysis is FDA-cleared and widely available globally.
  • HeartFlow's AI-driven technology provides personalized 3D heart models for precise diagnostics.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Remote Work Options

Stock Options

401(k) Company Match